Nágila Raquel Teixeira Damasceno

Prof. Nágila Raquel Teixeira Damasceno

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
JBJonas Burén
Jonas Burén
MEMadelene Ericsson
Madelene Ericsson
NDNágila Raquel Teixeira Damasceno
Nágila Raquel Teixeira Damasceno
ASAnna Sjödin
Anna Sjödin
Ketogenic low-carbohydrate high-fat (LCHF) diets are popular among young, healthy, normal-weight individuals for various reasons. We aimed to investigate the effect of a ketogenic LCHF diet on low-density lipoprotein (LDL) cholesterol (primary outcome), LDL cholesterol subfractions and conventional cardiovascular risk factors in the blood of healthy, young, and normal-weight women. The study was a randomized, controlled, feeding trial with crossover design. Twenty-four women were assigned to a 4 week ketogenic LCHF diet (4% carbohydrates; 77% fat; 19% protein) followed by a 4 week National Food Agency recommended control diet (44% carbohydrates; 33% fat; 19% protein), or the reverse sequence due to the crossover design. Treatment periods were separated by a 15 week washout period. Seventeen women completed the study and treatment effects were evaluated using mixed models. The LCHF diet increased LDL cholesterol in every woman with a treatment effect of 1.82 mM (p < 0.001). In addition, Apolipoprotein B-100 (ApoB), small, dense LDL cholesterol as well as large, buoyant LDL cholesterol increased (p < 0.001, p < 0.01, and p < 0.001, respectively). The data suggest that feeding healthy, young, normal-weight women a ketogenic LCHF diet induces a deleterious blood lipid profile. The elevated LDL cholesterol should be a cause for concern in young, healthy, normal-weight women following this kind of LCHF diet.

28 September 2011 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
ISIsis T Silva
Isis T Silva
AMAna Pq Mello
Ana Pq Mello
NDNágila Raquel Teixeira Damasceno
Nágila Raquel Teixeira Damasceno
The association of cardiovascular events with Lp-PLA2has been studied continuously today. The enzyme has been strongly associated with several cardiovascular risk markers and events. Its discovery was directly related to the hydrolysis of the platelet-activating factor and oxidized phospholipids, which are considered protective functions. However, the hydrolysis of bioactive lipids generates lysophospholipids, compounds that have a pro-inflammatory function. Therefore, the evaluation of the distribution of Lp-PLA2in the lipid fractions emphasized the dual role of the enzyme in the inflammatory process, since the HDL-Lp-PLA2enzyme contributes to the reduction of atherosclerosis, while LDL-Lp-PLA2stimulates this process. Recently, it has been verified that diet components and drugs can influence the enzyme activity and concentration. Thus, the effects of these treatments on Lp-PLA2may represent a new kind of prevention of cardiovascular disease. Therefore, the association of the enzyme with the traditional assessment of cardiovascular risk may help to predict more accurately these diseases.

1 October 2014 in Clinics
Verified
Journal Article
Open access
PLPatricia Azevedo de Lima
Patricia Azevedo de Lima
LSLetícia Sampaio
Letícia Sampaio
NDNágila Raquel Teixeira Damasceno
Nágila Raquel Teixeira Damasceno
A ketogenic diet is an important therapy used in the control of drug-refractory seizures. Many studies have shown that children and adolescents following ketogenic diets exhibit an over 50% reduction in seizure frequency, which is considered to be clinically relevant. These benefits are based on a diet containing high fat (approximately 90% fat) for 24 months. This dietary model was proposed in the 1920s and has produced variable clinical responses. Previous studies have shown that the mechanisms underlying seizure control involve ketone bodies, which are produced by fatty acid oxidation. Although the pathways involved in the ketogenic diet are not entirely clear, the main effects of the production of ketone bodies appear to be neurotransmitter modulation and antioxidant effects on the brain. This review highlights the impacts of the ketogenic diet on the modulation of neurotransmitters, levels of biogenic monoamines and protective antioxidant mechanisms of neurons. In addition, future perspectives are proposed.

22 February 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
SRSujatha Rajaram
Sujatha Rajaram
NDNágila Raquel Teixeira Damasceno
Nágila Raquel Teixeira Damasceno
RBRibanna Aparecida Marques Braga
Ribanna Aparecida Marques Braga
RMRaquel Martinez
Raquel Martinez
PKPenny Kris-Etherton
Penny Kris-Etherton
ASAleix Sala-Vila
Aleix Sala-Vila
Oxidative stress and inflammation are mediators in the pathophysiology of several non-communicable diseases (NCDs). Tree nuts and peanuts lower risk factors of cardiometabolic disease, including blood lipids, blood pressure and insulin resistance, among others. Given their strong antioxidant/anti-inflammatory potential, it is plausible that nuts may also exert a favorable effect on inflammation and oxidative stress. Evidence from systematic reviews and meta-analyses of cohort studies and randomized controlled trials (RCTs) suggest a modest protective effect of total nuts; however, the evidence is inconsistent for specific nut types. In this narrative review, the state of evidence to date is summarized for the effect of nut intake on biomarkers of inflammation and oxidative stress, and an attempt is made to define the gaps in research while providing a framework for future research. Overall, it appears that some nuts, such as almonds and walnuts, may favorably modify inflammation, and others, such as Brazil nuts, may favorably influence oxidative stress. There is a pressing need for large RCTs with an adequate sample size that consider different nut types, and the dose and duration of nut intervention, while evaluating a robust set of biomarkers for inflammation and oxidative stress. Building a stronger evidence base is important, especially since oxidative stress and inflammation are mediators of many NCDs and can benefit both personalized and public health nutrition.

5 May 2025 in European Heart Journal
Verified
Journal Article
Open access
MMMarcello Ricardo Paulista Markus
Marcello Ricardo Paulista Markus
TITill Ittermann
Till Ittermann
JMJoany Mariño
Joany Mariño
SSSabine Schipf
Sabine Schipf
MBMartin Bahls
Martin Bahls
MDMarcus Dörr
Marcus Dörr
Background and Aims: Associations of hyperlipidaemia and inflammation with the risk for incident major adverse cardiovascular events (MACEs) were analysed in individuals with and without cholesterol-lowering medication therapy. Methods: Data from 322,922 participants (55.9% women) aged 38 to 73 years from the UK Biobank were included. Longitudinal associations of low-density lipoprotein cholesterol (LDL-C), lipoprotein(a) [Lp(a)], and high-sensitivity C-reactive protein (Hs-CRP), both individually and in combination, were analysed with the risk for incident MACEs using Cox regression models, stratified by cholesterol-lowering medication use. Results: During a median follow-up of 13.7 years, 31,295 (9.69%) participants had incident MACEs. The incidence was 8.32% in non-users and 18.6% in users of cholesterol-lowering medication. Higher LDL-C levels were associated with the highest risk for MACEs, followed by Lp(a) and Hs-CRP. One higher standard deviation in LDL-C, Lp(a), and Hs-CRP was associated with a 13%, 8%, and 6% greater risk for MACEs in non-users and 11%, 7%, and 6% in cholesterol-lowering medication users, respectively. When combined, LDL-C, Lp(a), and Hs-CRP demonstrated a synergistic effect. Compared with individuals with all three biomarkers at or below the 75th percentile, those with all three biomarkers above the 75th percentile had a 77% higher risk for incident MACEs among non-users and a 58% higher risk among those on cholesterol-lowering medications. Conclusions: Hyperlipidaemia and inflammation independently and synergistically contribute to an increased risk for incident cardiovascular events. The magnitude of risk is more closely related to serum biomarker concentrations than to the use or not of cholesterol-lowering medications.

1 October 2016 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
MAMirelli Dantas Andrade
Mirelli Dantas Andrade
LGLaura Fantazzini Grandisoli
Laura Fantazzini Grandisoli
ASAlyne Mayumi Sakumoto
Alyne Mayumi Sakumoto
CPCaroline Pappiani
Caroline Pappiani
SASamantha Caesar de Andrade
Samantha Caesar de Andrade
NDNágila Raquel Teixeira Damasceno
Nágila Raquel Teixeira Damasceno
Key words: Conicity index; diabetes; hypertension; hyperglycemia